IRLAB Therapeutics AB (publ) (STO:IRLAB.A)

Sweden · Delayed Price · Currency is SEK

1.732

-0.032 (-1.81%)

Sep 2, 2026, 5:29 PM CET

IRLAB Therapeutics AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	262	167	558	389	1,987	2,277
Market Cap Growth	2.95%	-69.99%	43.33%	-80.42%	-12.75%	4.76%
Enterprise Value	252	87	527	271	1,699	1,853
Last Close Price	1.76	1.93	9.93	6.93	35.38	40.65

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	-	-	43.97
Forward PE	-	4.43	-	-	-	-
PS Ratio	3.31	2.91	5.89	68.51	32.49	10.96
PB Ratio	2.70	5.45	17.09	3.36	6.83	5.70
P/TBV Ratio	5.22	-	-	5.65	8.14	6.38
P/FCF Ratio	-	-	-	-	-	17.80
P/OCF Ratio	-	-	-	-	-	17.70

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	3.18	1.51	5.57	47.82	27.79	8.92
EV/EBITDA Ratio	-	-	-	-	-	34.92
EV/EBIT Ratio	-	-	-	-	-	35.25
EV/FCF Ratio	-	-	-	-	-	14.49

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.25	0.98	1.85	0.24	0.01	0.02
Debt / EBITDA Ratio	-	-	-	-	-	0.12
Debt / FCF Ratio	-	-	-	-	-	0.05
Net Debt / Equity Ratio	-0.10	-1.69	-0.20	-0.72	-0.85	-0.99
Net Debt / EBITDA Ratio	0.26	0.60	0.09	0.47	2.24	-7.45
Net Debt / FCF Ratio	0.15	0.94	0.10	0.51	1.71	-3.09
Asset Turnover	0.53	0.42	0.60	0.02	0.15	0.49
Quick Ratio	1.55	0.77	0.77	3.28	8.19	5.95
Current Ratio	1.55	0.80	0.80	3.37	8.31	6.07
Return on Equity (ROE)	-155.06%	-347.29%	-112.03%	-87.48%	-32.86%	13.86%
Return on Assets (ROA)	-16.16%	-39.27%	-29.11%	-44.96%	-17.59%	7.80%
Return on Capital Employed (ROCE)	-39.80%	-283.30%	-201.70%	-128.30%	-38.50%	13.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-20.52%	-65.75%	-14.91%	-45.72%	-5.71%	2.27%
FCF Yield	-25.55%	-33.00%	-11.80%	-42.45%	-7.32%	5.62%
Buyback Yield / Dilution	-61.05%	-29.17%	-	-0.07%	-0.16%	-8.54%